SCHEMBL4647650

SCHEMBL4647650

CC(=O)c1cccc(-c2cc3c(c(S(=O)(=O)O)c2)OCC3)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP10 Q53GL7 1/20 0.43
PARP11 Q9NR21 1/20 0.43
TDP2 O95551 1/20 0.40
DHFR P00374 1/20 0.39
GRIA2 P42262 2/20 0.36
BRD4 O60885 1/20 0.36
BRD2 P25440 1/20 0.36
CREBBP Q92793 1/20 0.36
FABP4 P15090 1/20 0.36
NR5A2 O00482 1/20 0.36
MAP4K4 O95819 2/20 0.36
CSNK1G2 P78368 2/20 0.36
CLK4 Q9HAZ1 2/20 0.36
MKNK2 Q9HBH9 2/20 0.36
MAP4K5 Q9Y4K4 2/20 0.36
PRKDC P78527 1/20 0.35
HRH3 Q9Y5N1 2/20 0.35
PARP1 P09874 1/20 0.35
NRP1 O14786 3/20 0.35
ALDH1A1 P00352 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4647763 0.86 HSD17B1 (0.37) MKNK2PARP1NRP1SMN1; SMN2
SCHEMBL4648162 0.84 NRP1 (0.40) PARP1NRP1
SCHEMBL4647930 0.83 PDE4B (0.40) PARP10PARP11TDP2FABP4PARP1
SCHEMBL4648561 0.81 PTPN1 (0.40) PARP10PARP11PARP1NRP1
SCHEMBL4647649 0.81 ALDH1A1 (0.39) TDP2MAP4K4MKNK2PARP1NRP1
SCHEMBL4648907 0.81 HDAC4 (0.40) ALDH1A1
SCHEMBL4738021 0.81 PARP10 (0.44) PARP10PARP11TDP2DHFRBRD4
SCHEMBL4648893 0.80 NRP1 (0.40) FABP4NRP1
SCHEMBL4649303 0.79 TDP2 (0.45) TDP2GRIA2BRD4CLK4ALDH1A1
SCHEMBL4648526 0.79 XDH (0.39) CLK4HRH3PGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080255117-A1 SULFONYLTRYPTOPHANOLS BAYER SCHERING PHARMA AG (DE) 2008-10-16 US claimed
WO-2008104597-A2 SULFONYLTRYPTOPHANOLS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-09-04 WO claimed
EP-1964834-A1 Sulphonyltryptophanols Bayer Schering Pharma Aktiengesellschaft (DE) 2008-09-03 EP claimed
US-20080255117-A1 SULFONYLTRYPTOPHANOLS BAYER SCHERING PHARMA AG (DE) 2008-10-16 US disclosed
WO-2008104597-A2 SULFONYLTRYPTOPHANOLS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-09-04 WO disclosed
EP-1964834-A1 Sulphonyltryptophanols Bayer Schering Pharma Aktiengesellschaft (DE) 2008-09-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080255117-A1 SULFONYLTRYPTOPHANOLS FSHR, NPY1R, GNRHR PARP10 589/4885PARP11 835/4885TDP2 1252/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.